For instance, the PLAGL2 and the PIK3CB were identified as key hub gene within the regulatory network that significantly associated with tumor immune infiltration and sensitivity of chemotherapeutic drugs for cancer52,53. This evidence concerns the gene PLAGL2 and neoplasm.